Humacyte, Inc.

Humacyte, Inc.verified

HUMA

Price:

$3.7

Market Cap:

$440.61M

Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its investigational HAVs are designed to be easily implanted into any patient without inducing a foreign body response or leading to immune rejection. The company is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodia...[Read more]

Industry

Biotechnology

IPO Date

2020-12-01

Stock Exchange

NASDAQ

Ticker

HUMA

The PE Ratio as of April 2024 (TTM) for Humacyte, Inc. (HUMA) is -3.46

According to Humacyte, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.46. This represents a change of 33.21% compared to the average of -2.60 of the last 4 quarters.

Humacyte, Inc. (HUMA) Historical PE Ratio (quarterly & annually)

How has HUMA PE Ratio performed in the past?

The mean historical PE Ratio of Humacyte, Inc. over the last ten years is 1.06. The current -3.46 PE Ratio has changed -32647.01% with respect to the historical average. Over the past ten years (40 quarters), HUMA's PE Ratio was at its highest in in the December 2021 quarter at 4.38. The PE Ratio was at its lowest in in the June 2021 quarter at -15.26.

Quarterly (TTM)
Annual

Average

1.06

Median

-0.86

Minimum

-2.65

Maximum

7.72

Humacyte, Inc. (HUMA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Humacyte, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual PE Ratio = 7.72

Minimum Annual Increase = -996.04%

Minimum Annual PE Ratio = -2.65

Quarterly (TTM)
Annual
YearPE RatioChange
2023-2.65-178.31%
20223.39-56.14%
20217.72-996.04%
2020-0.86-62.17%

Humacyte, Inc. (HUMA) Average PE Ratio

How has HUMA PE Ratio performed in the past?

The current PE Ratio of Humacyte, Inc. (HUMA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

2.82

5-year avg

1.06

10-year avg

1.06

Humacyte, Inc. (HUMA) PE Ratio vs. Peers

How is HUMA’s PE Ratio compared to its peers?

Humacyte, Inc.’s PE Ratio is greater than Crinetics Pharmaceuticals, Inc. (-13.72), less than Viridian Therapeutics, Inc. (-2.99), greater than Cytokinetics, Incorporated (-12.52), greater than Structure Therapeutics Inc. (-18.62), greater than Icosavax, Inc. (-8.27), greater than Immunocore Holdings plc (-39808.09), greater than Mirum Pharmaceuticals, Inc. (-7.02), greater than Larimar Therapeutics, Inc. (-7.84), less than KalVista Pharmaceuticals, Inc. (-3.26), greater than Lyra Therapeutics, Inc. (-4.76), less than Theseus Pharmaceuticals, Inc. (-3.19), greater than Kura Oncology, Inc. (-9.41), greater than Nurix Therapeutics, Inc. (-5.24), less than Seer, Inc. (-1.29), less than Quantum-Si incorporated (-2.54), less than HCW Biologics Inc. (-2.37), greater than MediciNova, Inc. (-7.71),

Build a custom stock screener for Humacyte, Inc. (HUMA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Humacyte, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Humacyte, Inc. (HUMA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Humacyte, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Humacyte, Inc.'s PE Ratio?

How is the PE Ratio calculated for Humacyte, Inc. (HUMA)?

What is the highest PE Ratio for Humacyte, Inc. (HUMA)?

What is the 3-year average PE Ratio for Humacyte, Inc. (HUMA)?

What is the 5-year average PE Ratio for Humacyte, Inc. (HUMA)?

How does the current PE Ratio for Humacyte, Inc. (HUMA) compare to its historical average?